TORREYPINES THERAPEU TPTX (NASDAQd)

$ 0.29
23:00
Sponsored by
Click here!
Change: unch (unch%)
Volume: 28,400

Avg. Volume: 22310
P/E Ratio: 0
EPS (Annual): -1.67
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 15,740
Institutional Shareholders: 26.37%
Last: 0.29
Change: unch (unch%)
Prev. Close: 0.29
Open: 0.28
Day's Range: 0.28 - 0.36
52wk Range: 0.27 - 5.96
Market Value: 4,570
Beta: 1.76
12-month EPS Change: 27.84%
Total Return Last 12 Months: -95.06%
Total Return Last 3 Years: -136.46%
Total Return Last 5 Years: -96.51%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: -48.26%


Headlines on TPTX

Long-term care company Golden Living names new CEO

(FORT SMITH, Ark.)The long-term care company Golden Living has announced a new chief executive officer. Dr. Neil Kurtz will serve as president and CEO of the Fort Smith-based company. Golden Living ...READ MORE
Aug 12, 2008 2:18PM
Keywords: TPTX

TorreyPines 2Q loss widens

(LA JOLLA, Calif.)Biopharmaceutical company TorreyPines Therapeutics Inc. said Friday its second-quarter loss widened on lower revenue and higher expenses. The company lost $7.5 million, or 47 cents...READ MORE
Aug 08, 2008 5:21PM
Keywords: TPTX

TorreyPines CEO resigns to take job elsewhere

(LA JOLLA, Calif.)Biopharmaceutical company TorreyPines Therapeutics Inc. said Friday President and Chief Executive Dr. Neil Kurtz is resigning. Kurtz is taking the president and CEO position at maj...READ MORE
Aug 08, 2008 5:17PM
Keywords: TPTX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement